Technical Milestone I. On a Research Program-by-Research Program basis, iTeos shall pay Adimab [***] within [***] of Adimab’s delivery to iTeos of an initial panel of Program Antibodies against the Target.
Appears in 2 contracts
Sources: Collaboration Agreement (iTeos Therapeutics, Inc.), Collaboration Agreement (iTeos Therapeutics, Inc.)